Navigation Links
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
Date:4/27/2011

s of the eye (wet age-related macular degeneration, central retinal vein occlusion, and diabetic macular edema), and certain cancers.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions, and cancer.  Additional information about Regeneron and recent news releases are available on Regeneron's web site at www.regeneron.com.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.  Bayer HealthCare, a subgroup of Bayer AG with annual sales of more than EUR 16.913 billion (2010), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany.  The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.  Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide.  Bayer HealthCare has a global workforce of 55.700 employees and is represented in more than 100 countries.  Find more information at www.bayerhealthcare.com.

Regeneron Forward-Looking Statements

This news release includes forward-looking statements that involve risks and uncertainties relating to future events and the future financial performance of Regeneron, and actual events or results may differ materially from these forward-looking statements.  These statements concern, and these risks and uncertainties include, among others, the nature, timing, and possible success and therapeutic applications of Regeneron's produ
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
2. Regeneron Announces Presentation at the 10th Annual Needham Healthcare Conference
3. Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
4. Regeneron Announces March 2011 Investor Conference Presentations
5. Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration
6. Regeneron Reports Full Year and Fourth Quarter 2010 Financial and Operating Results
7. Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET
8. Regeneron Announces Presentation at the ISI Annual Conference
9. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
10. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
11. Christine A. Poon Elected to Regeneron Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 The global ... USD 49.12 billion by 2020, growing at a CAGR ... new report by Grand View Research, Inc. Monitoring services ... 49.7% from 2014 to 2020.      (Logo: ... along with rising incidences of chronic diseases such as ...
(Date:8/27/2015)... 27, 2015 ieCrowd™ today announced the ... development of the company,s supplemental oxygen delivery device, ... being developed by ieCrowd,s subsidiary Smart Oxygen Solutions ... demand for oxygen based on level of activity.  ... for the Smart Oxygen device would require a ...
(Date:8/27/2015)... , Aug. 27, 2015   Proxsys ... Provider (IOPP™) is expanding its population health ... medication-focused transition of care program for hospitals ... Management," provides hospitals with technology systems and ... measures that have been mandated by Center ...
Breaking Medicine Technology:mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
... Lilly and Company (NYSE: LLY ) has ... for Working Mothers by Working Mother magazine ... http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO) (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO) Celebrating its ... 100 Best Companies initiative selects the nation,s top companies ...
... Wolters Kluwer Health , a leading provider of information ... medicine, nursing, allied health and pharmacy, has announced an ... (JBI), a recognized global leader in evidence-based healthcare resources ... of an expansion of the nursing, allied health, and ...
Cached Medicine Technology:Lilly Celebrates 16th Consecutive Year as One of 100 Best Companies for Working Mothers 2Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources 2Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources 3Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources 4
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... On October 3, 2015, BethAnn Telford of ... North Rim of the Grand Canyon with a shared mission: to beat brain cancer. ... canyon floor, across the canyon, then up to the South Rim over 21.1 miles and ...
(Date:8/27/2015)... ... August 27, 2015 , ... Keck Graduate Institute (KGI), ... received their White Coats at a formal ceremony recognizing them as members of the ... profession on Saturday, August 22. Symbolizing dedication to clinical service and patient care, the ...
(Date:8/27/2015)... ... August 27, 2015 , ... Workflow in labs has ... (qPCR) in the last decade. New features such as multiplexing, microfluidics, and ... flipside, where do lab managers, technicians, and researchers find handy metrics to compare ...
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny ... of just 20 adult-only medical centers in the United States to receive international ... and lungs. The Extracorporeal Life Support Organization (ELSO) , an international consortium ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... The Naderi ... now be offering Kybella, a cutting-edge, noninvasive procedure to improve submental fat. The ... Kybella provides permanent results without surgery. Dr. Kulak is the only Board Certified ...
Breaking Medicine News(10 mins):Health News:Women Athletes Cross the Grand Canyon to Raise Funds for Brain Cancer Research – October 3rd 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 3Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 4Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3
... holds press conferenceEPHRATA, Pa., April 29 Did ... diagnosed with breast cancer in Pennsylvania who are uninsured or ... - are not aware of the program or how it ... Breast Cancer Coalition (PBCC), in partnership with Senator Vince Hughes, ...
... Up Its ActNEW YORK, April 29 Today, Senator ... by introducing the Safe Baby Products Act, which directs ... contaminants in personal care products marketed to or used ... study by the Campaign for Safe Cosmetics, which revealed ...
... as the lead organizational and strategic planning consultant. Led by General ... of the new healthcare delivery organization. , ... (PRWEB) April 29, 2009 ... care hospital. The hospital will be part of a health village ...
... -- Aesthetic Medical Educators Training (AMET) ... on Aesthetic Procedures over the past five years. ... physicians, nurses, physician assistants and dentists, all of ... practice.These medical professionals have been trained on a ...
... CITY, April 29 Grupo Aeroportuario del Sureste, S.A.B. ... the first privatized airport group in Mexico and operator ... Mexico, announced today that on April 26, 2009 the Mexican ... ("Swine Flu") in Mexico. On April 28, 2009 the World ...
... Controls Limit Vaccine SuppliesDALLAS, April 29 Fears of ... new vaccines, as well as meeting public demand for ... National Center for Policy Analysis. "We are facing ... six vaccines for common childhood illnesses," said NCPA Senior ...
Cached Medicine News:Health News:Free Treatment for Breast Cancer Available in Pennsylvania 2Health News:New Federal Legislation Targets Toxic Chemicals in Baby Bath Products 2Health News:Aesthetic Medical Educators Training Successfully Trains Over 2,000 Medical Professionals on Aesthetic Procedures 2Health News:Swine Flu Outbreak Illustrates Problems in Vaccine Development 2
... Top Rotation provides uncommon bi-directional flexibility, ... Hercules 6700B eliminates any conflicts between ... while providing ample leg room for ... procedures. Removable back and leg sections ...
... The schaerer axis 800 ... specially designed for those ... C-arm access. The stability, ... and the offset positioned ...
... operating table for any application. The ... unlimited C-arm access. High stability guarantees ... and cardiovascular procedures. An extension device ... can easily be attached for orthopedic ...
... The anatomy of the human body set ... new arcus-family. Thanks to the special concept of ... in all positions ergonomically adapts to the patient ... available when the C-arm is being utilised. The ...
Medicine Products: